Drug shortages homepage
Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.
A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.
Below are the newest and most recently updated Shortage and Discontinuation reports.
Shortage Reports
| Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
|---|---|---|---|---|---|---|
| PROTAMINE SULFATE INJECTION, USP | FRESENIUS KABI CANADA LTD | Resolved | 10MG | Updated Report | 2019-08-17 | 90060 |
| TERBINAFINE | SANIS HEALTH INC | Actual shortage | 250MG | Updated Report | 2019-08-17 | 90836 |
| FOMEPIZOLE FOR INJECTION | STERIMAX INC | Actual shortage | 1G | Updated Report | 2019-08-17 | 91678 |
| COZAAR | MERCK CANADA INC | Resolved | 100MG | Updated Report | 2019-08-17 | 88873 |
| APO-EMTRICITABINE-TENOFOVIR | APOTEX INC | Resolved | 300MG 200MG | Updated Report | 2019-08-17 | 89158 |
| BREVIBLOC PREMIXED INJECTION | BAXTER CORPORATION | Actual shortage | 10MG | Updated Report | 2019-08-17 | 91707 |
| 0.9% SODIUM CHLORIDE INJECTION, USP | BAXTER CORPORATION | Actual shortage | 900MG | Updated Report | 2019-08-17 | 91720 |
| 0.9% SODIUM CHLORIDE INJECTION, USP | BAXTER CORPORATION | Actual shortage | 900MG | Updated Report | 2019-08-17 | 91723 |
| COZAAR | MERCK CANADA INC | Actual shortage | 50MG | Updated Report | 2019-08-16 | 88869 |
| 0.9% SODIUM CHLORIDE INJECTION, USP | BAXTER CORPORATION | Actual shortage | 900MG | Updated Report | 2019-08-16 | 91156 |
| TRICIRA LO | APOTEX INC | Actual shortage | 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG | Updated Report | 2019-08-16 | 80931 |
| APO-AMOXI CLAV | APOTEX INC | Actual shortage | 875MG 125MG | Updated Report | 2019-08-16 | 87057 |
| APO-OLMESARTAN | APOTEX INC | Actual shortage | 40MG | Updated Report | 2019-08-16 | 55287 |
| POTASSIUM CHLORIDE INJECTION | BAXTER CORPORATION | Actual shortage | 7.46MG | Updated Report | 2019-08-16 | 89426 |
| TWINRIX | GLAXOSMITHKLINE INC | Actual shortage | 720UNIT 20MCG | Updated Report | 2019-08-16 | 83033 |
| TRIZIVIR | VIIV HEALTHCARE ULC | Anticipated shortage | 300MG 300MG 150MG | Updated Report | 2019-08-16 | 90619 |
| JALYN | GLAXOSMITHKLINE INC | Resolved | 0.4MG 0.5MG | Updated Report | 2019-08-16 | 84337 |
| AURO-QUETIAPINE | AURO PHARMA INC | Actual shortage | 25MG | Updated Report | 2019-08-16 | 89540 |
| AURO-LACOSAMIDE | AURO PHARMA INC | Actual shortage | 100MG | Updated Report | 2019-08-16 | 90209 |
| AURO-BETAHISTINE | AURO PHARMA INC | Actual shortage | 16MG | New Report | 2019-08-16 | 91692 |
Discontinuation Reports
| Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
|---|---|---|---|---|---|---|
| TEVA-LISINOPRIL (TYPE Z) | TEVA CANADA LIMITED | Discontinued | 10MG | New Report | 2019-08-15 | 91648 |
| DIANEAL PD4 CAPD SOLUTION WITH 1.5% DEXTROSE AND 2.5MEQ/L CALCIUM | BAXTER CORPORATION | To be discontinued | 448MG 1.5G 5.08MG 18.3MG 538MG | New Report | 2019-08-12 | 91388 |
| DIANEAL PD4 CAPD SOLUTION WITH 2.5% DEXTROSE AND 2.5MEQ/L CALCIUM | BAXTER CORPORATION | To be discontinued | 448MG 2.5G 5.08MG 18.3MG 538MG | New Report | 2019-08-12 | 91392 |
| DIANEAL PD 101 CAPD SOLUTION W 1.5% DEXTROSE | BAXTER CORPORATION | To be discontinued | 392MG 1.5G 15.2MG 23.9MG 567MG | New Report | 2019-08-12 | 91395 |
| DIANEAL PD 101 CAPD SOLUTION W 2.5% DEXTROSE | BAXTER CORPORATION | To be discontinued | 392MG 2.5G 15.2MG 23.9MG 567MG | New Report | 2019-08-12 | 91399 |
| NUTRINEAL PD4 | BAXTER CORPORATION | To be discontinued | 57MG 71.4MG 27MG 102MG 107.1MG 448MG 64.6MG 95.1MG 5.1MG 18.4MG 538MG 85MG 51MG 59.5MG 30MG 95.5MG 51MG 139.3MG 85MG | New Report | 2019-08-12 | 91385 |
| NUTRINEAL PD4 | BAXTER CORPORATION | To be discontinued | 57MG 71.4MG 27MG 102MG 107.1MG 448MG 64.6MG 95.1MG 5.1MG 18.4MG 538MG 85MG 51MG 59.5MG 30MG 95.5MG 51MG 139.3MG 85MG | New Report | 2019-08-12 | 91382 |
| NUTRINEAL PD4 | BAXTER CORPORATION | To be discontinued | 57MG 71.4MG 27MG 102MG 107.1MG 448MG 64.6MG 95.1MG 5.1MG 18.4MG 538MG 85MG 51MG 59.5MG 30MG 95.5MG 51MG 139.3MG 85MG | New Report | 2019-08-12 | 91378 |
| TRAMADOL / ACETAMINOPHEN | SIVEM PHARMACEUTICALS ULC | To be discontinued | 37.5MG 325MG | Updated Report | 2019-08-12 | 86439 |
| TETRACYCLINE | AA PHARMA INC | To be discontinued | 250MG | New Report | 2019-08-10 | 65441 |
| RAN-RISPERIDONE | RANBAXY PHARMACEUTICALS CANADA INC. | Discontinued | 3.0MG | Updated Report | 2019-08-10 | 91284 |
| VIADERM KC ONT | TARO PHARMACEUTICALS INC | Discontinued | 1MG 100000UNIT 0.25MG 2.5MG | Updated Report | 2019-08-10 | 91315 |
| LYDERM GEL 0.05% | TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC. | Discontinued | 0.05% | Updated Report | 2019-08-10 | 91245 |
| RAN-ESOMEPRAZOLE | RANBAXY PHARMACEUTICALS CANADA INC. | Discontinued | 20MG | Updated Report | 2019-08-10 | 91261 |
| RAN-ESOMEPRAZOLE | RANBAXY PHARMACEUTICALS CANADA INC. | Discontinued | 40MG | Updated Report | 2019-08-10 | 91266 |
| RAN-ESOMEPRAZOLE | RANBAXY PHARMACEUTICALS CANADA INC. | Discontinued | 40MG | Updated Report | 2019-08-10 | 91269 |
| RAN-OLANZAPINE ODT | RANBAXY PHARMACEUTICALS CANADA INC. | Discontinued | 5MG | Updated Report | 2019-08-10 | 91278 |
| RAN-OLANZAPINE ODT | RANBAXY PHARMACEUTICALS CANADA INC. | Discontinued | 20MG | Updated Report | 2019-08-10 | 91281 |
| APO-ROSUVASTATIN | APOTEX INC | Discontinued | 40MG | Updated Report | 2019-08-08 | 60772 |
| APO ACETAMINOPHEN TAB 500MG | APOTEX INC | Discontinued | 500MG | Updated Report | 2019-08-08 | 70807 |
